208 related articles for article (PubMed ID: 34577048)
41. The yin and yang of cannabis-induced psychosis: the actions of Δ(9)-tetrahydrocannabinol and cannabidiol in rodent models of schizophrenia.
Arnold JC; Boucher AA; Karl T
Curr Pharm Des; 2012; 18(32):5113-30. PubMed ID: 22716133
[TBL] [Abstract][Full Text] [Related]
42. Peripheral, but not central effects of cannabidiol derivatives: mediation by CB(1) and unidentified receptors.
Fride E; Ponde D; Breuer A; Hanus L
Neuropharmacology; 2005 Jun; 48(8):1117-29. PubMed ID: 15910887
[TBL] [Abstract][Full Text] [Related]
43. Cannabidiol attenuates cardiac dysfunction, oxidative stress, fibrosis, and inflammatory and cell death signaling pathways in diabetic cardiomyopathy.
Rajesh M; Mukhopadhyay P; Bátkai S; Patel V; Saito K; Matsumoto S; Kashiwaya Y; Horváth B; Mukhopadhyay B; Becker L; Haskó G; Liaudet L; Wink DA; Veves A; Mechoulam R; Pacher P
J Am Coll Cardiol; 2010 Dec; 56(25):2115-25. PubMed ID: 21144973
[TBL] [Abstract][Full Text] [Related]
44. Effects of Cannabidiol and Delta-9-Tetrahydrocannabinol on Emotion, Cognition, and Attention: A Double-Blind, Placebo-Controlled, Randomized Experimental Trial in Healthy Volunteers.
Woelfl T; Rohleder C; Mueller JK; Lange B; Reuter A; Schmidt AM; Koethe D; Hellmich M; Leweke FM
Front Psychiatry; 2020; 11():576877. PubMed ID: 33304282
[TBL] [Abstract][Full Text] [Related]
45. Content versus Label Claims in Cannabidiol (CBD)-Containing Products Obtained from Commercial Outlets in the State of Mississippi.
Gurley BJ; Murphy TP; Gul W; Walker LA; ElSohly M
J Diet Suppl; 2020; 17(5):599-607. PubMed ID: 32431186
[TBL] [Abstract][Full Text] [Related]
46. Regulatory Effects of Cannabidiol on Mitochondrial Functions: A Review.
Chan JZ; Duncan RE
Cells; 2021 May; 10(5):. PubMed ID: 34069407
[TBL] [Abstract][Full Text] [Related]
47. Cannabidiol (CBD) but not tetrahydrocannabinol (THC) dysregulate in vitro decidualization of human endometrial stromal cells by disruption of estrogen signaling.
Almada M; Amaral C; Oliveira A; Fernandes PA; Ramos MJ; Fonseca BM; Correia-da-Silva G; Teixeira N
Reprod Toxicol; 2020 Apr; 93():75-82. PubMed ID: 31953017
[TBL] [Abstract][Full Text] [Related]
48. Δ-9-Tetrahydrocannabinol and Cannabidiol produce dissociable effects on prefrontal cortical executive function and regulation of affective behaviors.
Szkudlarek HJ; Desai SJ; Renard J; Pereira B; Norris C; Jobson CEL; Rajakumar N; Allman BL; Laviolette SR
Neuropsychopharmacology; 2019 Mar; 44(4):817-825. PubMed ID: 30538288
[TBL] [Abstract][Full Text] [Related]
49. A Critical Review of the Role of the Cannabinoid Compounds Δ
Jones É; Vlachou S
Molecules; 2020 Oct; 25(21):. PubMed ID: 33113776
[TBL] [Abstract][Full Text] [Related]
50. Differential transcriptional profiles mediated by exposure to the cannabinoids cannabidiol and Δ9-tetrahydrocannabinol in BV-2 microglial cells.
Juknat A; Pietr M; Kozela E; Rimmerman N; Levy R; Coppola G; Geschwind D; Vogel Z
Br J Pharmacol; 2012 Apr; 165(8):2512-28. PubMed ID: 21542829
[TBL] [Abstract][Full Text] [Related]
51. Using (+)-Carvone to access novel derivatives of (+)-
Golliher AE; Tenorio AJ; Dimauro NO; Mairata NR; Holguin FO; Maio W
Tetrahedron Lett; 2021 Mar; 67():. PubMed ID: 34658452
[TBL] [Abstract][Full Text] [Related]
52. Cannabidiol prevents LPS-induced microglial inflammation by inhibiting ROS/NF-κB-dependent signaling and glucose consumption.
Dos-Santos-Pereira M; Guimarães FS; Del-Bel E; Raisman-Vozari R; Michel PP
Glia; 2020 Mar; 68(3):561-573. PubMed ID: 31647138
[TBL] [Abstract][Full Text] [Related]
53. Cannabidiol or CBD Oil: Help, Hope, and Hype for Psychiatric and Neurologic Conditions.
Newton M; Newton DW
J Am Psychiatr Nurses Assoc; 2020; 26(5):447-457. PubMed ID: 32508204
[No Abstract] [Full Text] [Related]
54. Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes.
De Petrocellis L; Ligresti A; Moriello AS; Allarà M; Bisogno T; Petrosino S; Stott CG; Di Marzo V
Br J Pharmacol; 2011 Aug; 163(7):1479-94. PubMed ID: 21175579
[TBL] [Abstract][Full Text] [Related]
55. Current Status and Prospects for Cannabidiol Preparations as New Therapeutic Agents.
Fasinu PS; Phillips S; ElSohly MA; Walker LA
Pharmacotherapy; 2016 Jul; 36(7):781-96. PubMed ID: 27285147
[TBL] [Abstract][Full Text] [Related]
56. Neuroprotective Effects of Cannabidiol but Not Δ
Landucci E; Mazzantini C; Lana D; Davolio PL; Giovannini MG; Pellegrini-Giampietro DE
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575932
[TBL] [Abstract][Full Text] [Related]
57. Cannabidiol induces expression of human cytochrome P450 1A1 that is possibly mediated through aryl hydrocarbon receptor signaling in HepG2 cells.
Yamaori S; Kinugasa Y; Jiang R; Takeda S; Yamamoto I; Watanabe K
Life Sci; 2015 Sep; 136():87-93. PubMed ID: 26187180
[TBL] [Abstract][Full Text] [Related]
58. Cannabidiol protects oligodendrocyte progenitor cells from inflammation-induced apoptosis by attenuating endoplasmic reticulum stress.
Mecha M; Torrao AS; Mestre L; Carrillo-Salinas FJ; Mechoulam R; Guaza C
Cell Death Dis; 2012 Jun; 3(6):e331. PubMed ID: 22739983
[TBL] [Abstract][Full Text] [Related]
59. The effects of cannabidiol (CBD) on Δ⁹-tetrahydrocannabinol (THC) self-administration in male and female Long-Evans rats.
Wakeford AGP; Wetzell BB; Pomfrey RL; Clasen MM; Taylor WW; Hempel BJ; Riley AL
Exp Clin Psychopharmacol; 2017 Aug; 25(4):242-248. PubMed ID: 28682102
[TBL] [Abstract][Full Text] [Related]
60. Molecular Pharmacology of Phytocannabinoids.
Turner SE; Williams CM; Iversen L; Whalley BJ
Prog Chem Org Nat Prod; 2017; 103():61-101. PubMed ID: 28120231
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
